Skip to main content Accessibility help
×
×
Home

Rechallenge with clozapine following leucopenia or neutropenia during previous therapy

  • Louisa R. Dunk (a1), Linda J. Annan (a2) and Christopher D. Andrews (a2)

Abstract

Background

Further treatment with clozapine is contraindicated in any patient who has previously experienced leucopenia or neutropenia during clozapine therapy.

Aims

To investigate the results of such a rechallenge in 53 patients.

Method

An analysis was made of the demographic, haematological and outcome data of patients in the UK and Ireland who were rechallenged with clozapine following leucopenia or neutropenia during previous clozapine therapy.

Results

Of 53 patients who were rechallenged, 20 (38%) experienced a further blood dyscrasia. In 17 of these 20 patients (85%) the second blood dyscrasia was more severe(P<0.001), in 12(60%) it lasted longer (P=0.0368) and in 17 (85%) it occurred more quickly on rechallenge (P<0.001). Of the original 53 patients, 55% (29 patients) are still receiving clozapine.

Conclusions

No clear risk factor for repeat blood dyscrasias was identified. Despite this, after risks and benefits have been considered, rechallenge may well be justified in some patients.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Rechallenge with clozapine following leucopenia or neutropenia during previous therapy
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Rechallenge with clozapine following leucopenia or neutropenia during previous therapy
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Rechallenge with clozapine following leucopenia or neutropenia during previous therapy
      Available formats
      ×

Copyright

Corresponding author

Dr L. R. Dunk, Histopathology Department, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK. E-mail: louisa.dunk@btinternet.com

Footnotes

Hide All

Declaration of interest

L. D. has undertaken consultancy for Novartis UK and Novartis Australia and received a fee from Novartis Australia for the preparation of this paper; she was formerly employed by Novartis UK. L. A. and C. A. are employed by Novartis UK.

Footnotes

References

Hide All
Ahn, Y. M., Jeong, S. H., Jang, H. S., et al (2004) Experience of maintaining clozapine medication in patients with ‘red-alert zone’ neutropenia: long-term follow-up results. International Clinical Psychopharmacology, 19, 97101.
Alvir, J. M. & Lieberman, J. A. (1994) A re-evaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience. Journal of Clinical Psychopharrnacology, 14, 8789.
Barrons, E., Johnson, E. & Nynkowski, P. (1996) Restarting clozapine: case report. Psychiatric Services, 47, 92.
Chengappa, K. N. R., Gopalani, A., Haught, M. K., et al (1996) The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF). Psychopharrnacology Bulletin, 32, 111121.
Frankenberg, F. R., Stormberg, D. & Gerson, S. L. (1994) Unsuccessful re-exposure to clozapine. Journal of Clinical Psychopharrnacology, 14, 428429.
Gerson, S. L. (1993) Clozapine – deciphering the risks. New England Journal of Medicine, 329, 204205.
Gerson, S. L. (1994) G-CSF and the management of clozapine-induced agranulocytosis. Journal of Clinical Psychiatry, 55, 139142.
Gerson, S. L. & Meltzer, H. (1992) Mechanisms of clozapine-induced agranulocytosis. Drug Safety, 7 (suppl. 1), 1725.
Gerson, S. L., Lieberman, J. A., Friedenberg, W. R., et al (1991) Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet, 338, 262263.
Grohmann, R., Schmidt, L. G., Spiess-Kiefer, C., et al (1989) Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AMÜP program. Psychopharrnacology, 99 (suppl), S109S112.
Idänpään-Heikkilä, J., Alhava, E., Olkinuora, M., et al (1977) Agranulocytosis during treatment with clozapine. European Journal of Clinical Pharmacology, 11, 193198.
Junghan, U., Albers, M. & Woggon, B. (1993) Increased risk of haematological side-effects in psychiatric patients treated with clozapine and carbamazepine. Pharmacopsychiatry, 26, 262.
Lieberman, J. A., Yunis, J., Egea, E., et al (1990) HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Archives of General Psychiatry, 47, 945948.
Lindstrom, L. H. (1988) The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatrica Scandinavica, 77, 524529.
Mangan, B. & Toal, M. J. (1994) A fatal complication of clozapine-induced agranulocytosis. Irish Journal of Psychological Medicine, 11, 138139.
Munro, J., O'Sullivan, D., Andrews, C., et al (1999) Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. British Journal of Psychiatry, 175, 576580.
Pirmohamed, M. & Park, K. (1997) Mechanism of clozapine-induced agranulocytosis: current status of research and implications for drug development. CNS Drugs, 7, 139158.
Povlsen, U. J., Noring, U., Fog, R., et al (1985) Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years. Acta Psychiatrica Scandinavica, 71, 176185.
Safferman, A. Z., Lieberman, J. A., Alvir, J. M., et al (1992) Rechallenge in clozapine-induced agranulocytosis. Lancet, 339, 12961297.
Safferman, A. Z., Lieberman, J. A., Zeman, D., et al (1993) Unrelated agranulocytosis in a patient taking clozapine. Journal of Clinical Psychopharmacology, 13, 218219.
Sénéchal, A., Landry, P., Deschamps, R., et al (2002) Neutropénie chez un patient traité avec la clozapine dans le contexte d'une polypharmacie. L'LEncéphale, 28, 567569.
Sperner-Unterweger, B., Czeipek, I., Gaggl, S., et al (1998) Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine. British Journal of Psychiatry, 172, 8284.
Valevski, A., Modai, I., Labav, M., et al (1993) Clozapine – lithium combined treatment and agranulocytosis. International Clinical Psychopharmacology, 8, 6365.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Rechallenge with clozapine following leucopenia or neutropenia during previous therapy

  • Louisa R. Dunk (a1), Linda J. Annan (a2) and Christopher D. Andrews (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *